Abstract

Peptide–nanoparticle conjugates (PNCs) have recently emerged as a versatile tool for biomedical applications. Synergism between the two promising classes of materials allows enhanced control over their biological behaviors, overcoming intrinsic limitations of the individual materials. Over the past decades, a myriad of PNCs has been developed for various applications, such as drug delivery, inhibition of pathogenic biomolecular interactions, molecular imaging, and liquid biopsy. This paper provides a comprehensive overview of existing technologies that have been recently developed in the broad field of PNCs, offering a guideline especially for investigators who are new to this field.

Details

Title
Peptide–nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms?
Author
Woo-jin, Jeong 1 ; Bu, Jiyoon 1 ; Kubiatowicz, Luke J 1 ; Chen, Stephanie S 1 ; Kim, YoungSoo 2 ; Hong, Seungpyo 3   VIAFID ORCID Logo 

1  Pharmaceutical Sciences Division, School of Pharmacy, The University of Wisconsin-Madison, Madison, WI, USA 
2  Integrated Science and Engineering Division, Department of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, Republic of Korea 
3  Pharmaceutical Sciences Division, School of Pharmacy, The University of Wisconsin-Madison, Madison, WI, USA; Yonsei Frontier Lab, Department of Pharmacy, Yonsei University, Seoul, Republic of Korea 
Pages
1-18
Publication year
2018
Publication date
Dec 2018
Publisher
Springer Nature B.V.
e-ISSN
21965404
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1186/s40580-018-0170-1
ProQuest document ID
2154546651
Copyright
Nano Convergence is a copyright of Springer, (2018). All Rights Reserved., © 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.